Hertzel C. Gerstein - Concepedia

Author

Hertzel C. Gerstein

Also Known As

, A Kurpad, Ajay Sood, Bergenstal, R. M, Dereck L. Hunt, Gerstein HC, Gerstein, Hertzel C, Gerstein, Hertzel C., H C Gerstein, H GERSTEIN

822

Publications

81.1K

Citations

122

H-Index

222

Concepts

All Affiliations

McMaster University Population Health Research Institute Hamilton Health Sciences University of Toronto Oregon Health & Science University

About

Hertzel C. Gerstein is an author at McMaster University specializing in medicine, diabetes, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	53	101	13.4K
2	Health Sciences	17	21	2.4K
3	Education	1	1	451
4	Engineering	1	1	13
5	Management	1	1	297

Hertzel C. Gerstein

305

Publications

43K

Citations

100

H-Index

Page 1

	Year	Citations
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseHealth PolicyCardiovascular Outcomes	2019	2.8K
Albuminuria and Risk of Cardiovascular Events, Death, and Heart Failure in Diabetic and Nondiabetic Individuals Hertzel C. Gerstein JAMA	2001	2.4K
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome Marc A. Pfeffer, Brian Claggett, Rafael Díaz, New England Journal of Medicine	2015	2.3K
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Jfe Mann, Hertzel C. Gerstein, Salim Yusuf PubMed	2000	2.1K
Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized Trial Johannes F.E. Mann, Hertzel C. Gerstein, Janice Pogue, Annals of Internal Medicine	2001	1.4K
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE) Sonia S. Anand, Salim Yusuf, V. Vuksan, The Lancet Cardiovascular EpidemiologyHealth PolicyCardiovascular DiseaseAtherosclerosisHealth Sciences	2000	1.1K
ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES STUDY GROUP. EFFECTS OF INTENSIVE GLUCOSE LOWERING IN TYPE 2 DIABETES Hertzel C. Gerstein, M E Miller, Robert P. Byington Metabolic SyndromeDiabetes ManagementDiabetes EpidemiologyHealth PolicyCardiovascular Disease	2010	987
Myocardial Injury after Noncardiac Surgery Fernando Botto, Pablo Alonso‐Coello, Matthew T.V. Chan, Anesthesiology	2014	943
Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial Infarction Klas Malmberg, Salim Yusuf, Hertzel C. Gerstein, Circulation	2000	751
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes Hertzel C. Gerstein, Naveed Sattar, Julio Rosenstock, New England Journal of Medicine	2021	719

Page 1